Commentary on Jack Dowie, "Decision validity should determine whether a generic or condition-specific HRQOL measure is used in health care decisions"

Health Economics

Volumn 11, Issue 1, 2002, Pages 9-12

  Guyatt, Gordon ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; HEALTH CARE; HEALTH CARE POLICY; HEALTH STATUS; HUMAN; INTERMETHOD COMPARISON; MEDICAL DECISION MAKING; OUTCOMES RESEARCH; PRIORITY JOURNAL; QUALITY OF LIFE; SENSITIVITY ANALYSIS; VALIDATION PROCESS;

CLINICAL TRIALS; COST-BENEFIT ANALYSIS; DECISION MAKING; EVIDENCE-BASED MEDICINE; HEALTH POLICY; HEALTH SERVICES RESEARCH; HUMANS; QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS; REPRODUCIBILITY OF RESULTS;

EID: 0036148331     PISSN: 10579230     EISSN: None     Source Type: Journal    
DOI: 10.1002/hec.666     Document Type: Article

References (34)

1. Assessing the responsiveness of functional scales to clinical change
2. Identification of clinically important changes in health status using receiver operating characteristic curves
3. Measuring change over time: Assessing the usefulness of evaluative instruments
4. Effect sizes for interpreting changes in health status
5. A comparison of different indices of responsiveness
6. Measuring functional outcomes in chronic disease: A comparison of traditional scales and a self-administered health status questionnaire in patients with rheumatoid arthritis
7. Sensitivity to change of the Roland-Morris back pain questionnaire: Part 1
8. A comparison of seven-point and visual analogue scales: Data from a randomized trial
9. Generic and specific measurement of health related quality of life in a clinical trial of respiratory rehabilitation
10. Comparisons of five health status instruments for orthopedic evaluation
11. Analysis of quality of life data from a randomized, placebo controlled heart-failure trial
12. Outcomes of add-on treatment with Lamotrigine in partial epilepsy
13. The impact of diuretic therapy on reported sexual function
14. Methotrexate in rheumatoid arthritis. Impact on quality of life assessed by traditional standard-item and individualized patient preference health status questionnaires
15. Prospective randomized controlled trial of respiratory rehabilitation
16. Effects of pulmonary rehabilitation on physiologic and psychosocial outcomes in patients with chronic obstructive pulmonary disease
17. Measurement of health status: Ascertaining the meaning of a change in quality-of-life questionnaire score
18. Determining a minimal important change in a disease-specific quality of life questionnaire
19. Measuring quality of life in children with Asthma
20. Interpretation of rhinoconjunctivitis quality of life questionnaire data
21. Health-related quality of life in patients treated with temozolomide versus procarbazine for recurrent glioblastoma multiforme
22. Health-related quality of life in men with metastatic prostate cancer treated with prednisone alone or mitoxantrone and prednisone
23. Assessing the clinical importance of symptomatic improvements. An illustration in rheumatology
24. Assessing the minimal important difference in symptoms: A comparison of two techniques
25. On the debate over methods for estimating the clinically important difference
26. Interpreting a small difference in functional status: The six minute walking test in chronic lung disease patients
27. The Crohn's disease activity index as a clinical instrument
28. Identifying meaningful intra-individual change standards for health-related quality of life measures
29. Interpreting pharmacoeconomic and quality of life clinical trial data for use in therapeutics
30. Quality of life and antihypertensive therapy in men: A comparison of enalapril and captopril
31. The significance of treatment effects: The clinical perspective
32. Interpreting treatment effects in randomized trials
33. The cost-effectiveness of auranofin